Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics - 5 Mar 2009

Liou Ying-Jay, Chen Mao-Liang, Wang Ying-Chieh, Chen Jen-Yeu, Liao Ding-Lieh, Bai Ya-Mei, Lin Chao-Cheng, Chen Tzu-Ting, Mo Geng-Han, Lai I-Ching

Abstract excerpt

Some patients treated chronically with antipsychotics develop tardive dyskinesia (TD), an abnormal involuntary movement disorder. Typical antipsychotics block D(2) dopamine receptors (D(2)DR) and produce D(2)DR supersensitivity. On contrary, regulators of G-protein signaling (RGS) can enhance the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dyskinesia, Drug-Induced

Share to Gene Frequency

Share to Haplotypes

Share to RGS Proteins

Share to Schizophrenia

Share to Young Adult

Source

Identifiers

PMID: 18548510
DOI: 10.1002/ajmg.b.30796

Genes

RGS9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18548510-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia.PMID 18548510Read ↗

Pharmacogenetics of tardive dyskinesia: an updated review of the literature.Semantic proximity Read ↗

Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication.Semantic proximity Read ↗

Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia.Semantic proximity Read ↗

Candidate gene-based association study of antipsychotic-induced movement disorders in long-stay psychiatric patients: a prospective study.Semantic proximity Read ↗

RGS4 is not a susceptibility gene for schizophrenia in Japanese: association study in a large case-control population.Semantic proximity Read ↗

[Polymorphism of RGS2 gene: genetic markers of risk for schizophrenia and pharmacogenetic markers of typical neuroleptics efficiency].Semantic proximity Read ↗

Analysis of genetic variations in the human melatonin receptor (MTNR1A, MTNR1B) genes and antipsychotics-induced tardive dyskinesia in schizophrenia.Semantic proximity Read ↗

Genetics of tardive dyskinesia: a review of progress over the past decade.Semantic proximity Read ↗

New insights into tardive dyskinesia genetics: Implementation of whole-exome sequencing approach.Semantic proximity Read ↗

Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated region.Semantic proximity Read ↗

An association study of RGS4 polymorphisms with clinical phenotypes of schizophrenia in a Chinese population.Semantic proximity Read ↗

[Genome-wide association analyses for neuroleptic-induced tardive dyskinesia].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.